Posted on May 29th, 2010 by Health News
The World Health Organization (WHO) has described the trends in some countries as “extremely worrisome” and asks governments to ban all tobacco advertising, promotion and sponsorship, and to eliminate tobacco smoke from all public and work places. WHO Director-General Dr Margaret Chan said that tobacco use is “neither liberating nor glamorous..it is addictive and [...]
No Comments »
Filed under: Women's Health
Posted on May 29th, 2010 by Health News
Stem cells derived from the human amniotic sac can become beating heart muscle cells, at least in rats, researchers said, offering the possibility of off-the-shelf stem cell therapy for heart attacks.
No Comments »
Filed under: General Health News
Posted on May 29th, 2010 by Health News
WASHINGTON (MedPage Today) — Senators will leave for Memorial Day recess without voting to stall a 21% cut in Medicare reimbursements to physicians.
No Comments »
Filed under: General Health News
Posted on May 29th, 2010 by Health News
ATLANTA (MedPage Today) — There was an 18% reduction in central line-associated bloodstream infections in the first half of 2009 compared with the previous three years, the first state-specific report on healthcare-associated infections showed.
No Comments »
Filed under: General Health News
Posted on May 29th, 2010 by Health News
Blacksmith Brands has recalled all lots of four Pediacare children’s cough and cold products that were manufactured for the company by McNeil Consumer Healthcare, makers of the Tylenol and Motrin products involved in last month’s massive recall.
No Comments »
Filed under: Pharmacy News
Posted on May 29th, 2010 by Health News
Advaxis, Inc., the live, attenuated Listeria monocytogenes biotechnology company, has dosed the first patient in its US Food and Drug Administration -approved, phase II clinical trial in cervical intraepithelial neoplasia, commonly known as cervical dysplasia.
No Comments »
Filed under: Pharmacy News
Posted on May 29th, 2010 by Health News
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 –30 in Athens, Greece.
No Comments »
Filed under: Pharmacy News
Posted on May 29th, 2010 by Health News
VIVUS, Inc. today announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 inhibitor therapy being investigated for the treatment of erectile dysfunction, will be presented next Tuesday at the American Urological Association 2010 Annual Meeting in San Francisco, California.
No Comments »
Filed under: Pharmacy News
Posted on May 29th, 2010 by Health News
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced the expansion of its collaboration with the U.S. Government to include the evaluation of Restanza’s activity against sexually transmitted infections (STI’s), such as gonorrhea.
No Comments »
Filed under: Pharmacy News
Posted on May 29th, 2010 by Health News
Nymox Pharmaceutical Corporation is pleased to announce the presenters and participants for the symposium and panel discussion on NX-1207, the Company’s Phase 3 drug for benign prostatic hyperplasia (BPH), to be held during the 2010 Annual Meeting of the American Urological Association in San Francisco at 3:00 p.m. June 1.
No Comments »
Filed under: Pharmacy News
